Arrowhead Pharma (ARWR) Stock Price, Quote & News

Company Profile

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, t...

Industry: Biotechnology

Sector: Healthcare

Phone: 626 304 3400

Fax: 626 304 3401

Website: arrowheadpharma.com

Address:

177 East Colorado Boulevard, Suite 700, Pasadena, United States

HokieStock May. 12 at 11:07 PM

$ARWR ARO-PNPLA3/resmetirom combo, Madrigal is making a bunch of combination for MASH focus and PNPLA3 is considered one of the top 3 genetic risk along with HSD. Would think this with an approved drug should also move closer if they hit the target benefits they desire.

0 · Reply

StockingStuffer2832 May. 12 at 8:01 PM

$ARWR pretty solid day in the midst of a red tape

0 · Reply

skeezbag May. 12 at 5:40 PM

$ARWR only two charts exist. Down really big and all day or up until 11am then tail down till 3ish

0 · Reply

NeverFadeTheOracle May. 12 at 5:29 PM

$ARWR

1 · Reply

ZacksSCR May. 12 at 2:16 PM

$ARWR Multiple Important Clinical Readouts in 2H26 https://buff.ly/mE6tEyz

0 · Reply

CapitalMonk May. 12 at 1:09 PM

$ARWR Price: $77.74 (+6.95%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±2.05% RSI: 60.8 | Momentum: Strong Momentum Volume: +19.5% vs avg Volatility: 3.73% Support: $63.98 | Resistance: $80.26 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25

0 · Reply

skeezbag May. 11 at 6:35 PM

$ARWR 50 cent spread at 230pm. Once again MM doing whatever the fuck they want when they want

0 · Reply